Evaluation of Carcinogenic Risks to Humans

James D Mckay

Genomic and transcriptomic characterization of atypical carcinoids of the lung

Trachea, bronchus and lung

Pathology

Lesley Katie Seymour

LACE-Bio-II: Identification, Validation and Implementation of Prognostic and/or P

Trachea, bronchus and lung

Pathology

Demetrius Albanes

ATBC Study

Trachea, bronchus and lung Testis Stomach Prostate Pancreas Oesophagus Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Leukaemia Larynx Kidney, renal pelvis and ureter Colorectum Brain, nervous system Bladder

William Lockwood

Longitudinal assessment of immune-tumor interactions during lung cancer progression

Trachea, bronchus and lung

Xue Sean Li

Gender Difference in Bladder Cancer Susceptibility

Bladder

Guilherme Godoy

ESTROGEN RECEPTOR TARGETED TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER

Bladder

Investigator from University of Lisbon

IL-7/IL-7R signaling networks in health and malignancy

Trachea, bronchus and lung Leukaemia Breast

Hematology and hematologic malignancies

Fred R Hirsch

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis

Trachea, bronchus and lung

Pathology

Jean William Pape

GHESKIO HIV Clinical Trial Unit

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri